Treatment outcomes of primary and secondary end points
| Treatment parameter | Placebo3-150 | Pancreatic enzyme therapy3-150 | p Value | Mean difference | 95% CI for the difference |
| Change in body weight (%) | −3.7 (4.4) | +1.2 (4.3) | 0.02 | 4.9 | 0.9 to 8.9 |
| Change in body weight (kg) | −2.2 (2.7) | +0.7 (2.5) | 0.02 | 2.8 | 0.4 to 5.2 |
| Change in fat absorption coefficient | −8 (25) | +12 (25) | 0.13 | 20 | −6 to 45 |
| Change in stool frequency per day | +0.2 (1.0) | −1.0 (1.9) | 0.07 | 1.2 | NA |
| Daily total caloric intake (MJ) | 6.66 (1.78) | 8.42 (1.88) | 0.04 | 1.76 | 0.08 to 3.44 |
| Daily fat intake (MJ) | 2.65 (0.94) | 3.31 (1.07) | 0.15 | 0.66 | −0.26 to 1.58 |
| Daily protein intake (MJ) | 0.92 (0.24) | 1.27 (0.30) | <0.01 | 0.36 | 0.11 to 0.61 |
| Daily carbohydrate intake (MJ) | 3.10 (0.95) | 3.81 (1.00) | 0.11 | 0.71 | 0.18 to 1.61 |
↵3-150 Mean (SD).